The relationship between facial annular erythema and anti-SS-A/Ro antibodies in three East Asian women

British Journal of Dermatology

Volumn 140, Issue 1, 1999, Pages 136-140

  Kawakami, T ^a   Saito, R ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti SS A Ro antibodies; Facial annular erythema; Sjogren syndrome; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; CD4 ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ASIAN; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ERYTHEMA; FACE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; SJOEGREN SYNDROME; SKIN MANIFESTATION; SUN EXPOSURE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIBODIES, ANTINUCLEAR; CD4-POSITIVE T-LYMPHOCYTES; DIAGNOSIS, DIFFERENTIAL; ERYTHEMA; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; MIDDLE AGED; SJOGREN'S SYNDROME; SKIN;

EID: 0033049297     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02623.x     Document Type: Article

References (22)

1. Teramoto N, Katayama I, Arai H et al. Annular erythema: A possible association with primary Sjögren's syndrome. J Am Acad Dermatol 1989; 20: 596-601.
2. Hoshino Y, Hashimoto T, Mimori T et al. Recurrent annular erythema associated with anti-SS-B/La antibodies: Analysis of the disease-specific epitope. Br J Dermatol 1992; 127: 608-13.
3. Katayama I, Teramoto N, Arai H et al. Annular erythema. A comparative study of Sjögren syndrome with subacute cutaneous lupus erythematosus. Int J Dermatol 1991; 30: 635-9.
4. Simmons-O'Brien E, Chen S, Watson R et al. One hundred anti-Ro (SS-A) antibody positive patients: A 10-year follow-up. Medicine 1995; 74: 109-30.
5. Hanafusa T, Pujol-Borrell R, Chiovato L, et al. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: Relevance for autoimmunity. Lancet 1983; ii: 1111-15.
6. Bottazo GF, Dean BM, McNally JM et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985; 313: 353-60.
7. Provost TT, Watson R, Simmons-O'Brien E. Anti-Ro (SS-A) antibody positive Sjögren's/lupus erythematosus overlap syndrome. Lupus 1997; 6: 105-11.
8. Greenspan J, Daniels T, Talal N, Sylvester R. The histopathology of Sjögren's syndrome in labial biopsies. Oral Surg 1974; 37: 217-30.
9. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
10. Pox RI, Robinson CA, Curd JG, et al. Sjögren's syndrome: Proposed criteria for classification. Arthritis Rheum 1986; 29: 577-85.
11. Vitali C, Bombardieri S, Moutsopoulos HM. Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective concerted action supported by the European community. Arthritis Rheum 1993; 36: 340-7.
12. Provost TT, Talal N, Harley JB et al. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus. Arch Dermatol 1988; 124: 63-71.
13. Nishikawa T, Provost TT. Differences in clinical, serologic, and immunogenetic features of white versus Oriental anti-SS-A/Ro-positive patients (Editorial.) J Am Acad Dermatol 1991; 25: 563-4.
14. Fronek Z, Timmermann LA, Alper CA et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum 1990; 33: 1542-53.
15. Moutsopoulos HM, Hooks JJ. Chan CC et al. HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. Ann Rheum Dis 1986; 45: 677-83.
16. Kaissouni JE, Bene MC, Faure GC. Investigation of activation markers demonstrates significant overexpression of the secretory component on salivary glands epithelial cells in Sjögren's syndrome. Clin Immunol Immunopathol 1996; 79: 236-43.
17. Pandya AG, Sontheimer RD, Cockerell CJ et al. Papulonodular mucinosis associated with systemic lupus erythematosus: Possible mechanisms of increased glycosaminoglycan accumulation. J Am Acad Dermatol 1995; 32: 199-205.
18. Woska H, Blaszczyk M, Jablonska S. Phototests in patients with various forms of lupus erythematosus. Int J Dermatol 1988; 28: 98-103.
19. Davis TL, Lyde CB, Davis BM, Sontheimer RD. Pertubation of experimental light induced erythema by passive transfer of serum from subacute cutaneous lupus erythematosus. J Invest Dermatol 1989; 92: 573-7.
20. Lee LA, Gaither KK, Coulter SN et al. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest 1989; 83: 1556-62.
21. Provost TT, Watson R. Anti-Ro (SS-A) HLA-DR3-positive women: The interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients. J Invest Dermatol 1993; 100: 14S-20S.
22. Miyagawa S, Dohi K, Shima H, Shirai T. HLA antigens in anti-Ro (SS-A) -positive patients with recurrent annular erythema. J Am Acad Dermatol 1993; 28: 185-8.